COP D病人急性发作期C反应蛋白与纤维蛋白原变化分析

摘要

Objective To explore the COPD patients with acute exacerbation of fibrinogen and C-reactive protein chan-ges. Methods The subjects of this study were hospital in January 2015 to August 2016 were treated over 40 patients with COPD as the experimental group, and the other to choose their health examination of 40 patients as a control group of healthy subjects, patients with COPD remission, acute exacerbation of fibrinogen and serum C-reactive protein application rate scattering detection and contrast nephe-lometry. Results Compared to the control group, the experimental group of patients in remission and acute exacerbation of fibrinogen and C-reactive protein levels were significantly higher, the difference comparison P<0. 05; while the experimental group compared to remission in patients with acute exacerbation of fibrinogen and C-reactive protein levels were significantly higher, the difference compar-ison P<0. 05. Conclusion In patients with acute exacerbation of COPD period fibrinogen and C-reactive protein detection, treatment and condition of the effective judgment, should be widely applied.%目的：探究COPD患者在急性发作期纤维蛋白原及C反应蛋白的变化情况。方法本研究对象为均为我院在2015年1月至2016年8月期间收治的40例COPD患者作为实验组，另选择其健康体检患者40例作为对照组，对健康体检者、 COPD患者缓解期、急性发作期的纤维蛋白原及血清C反应蛋白应用速率散射比浊法进行检测和对比。结果相比于对照组，实验组患者缓解期及急性发作期纤维蛋白原及C反应蛋白水平均明显较高，差异对比P<0.05；同时实验组患者急性发作期相比缓解期纤维蛋白原及C反应蛋白水平均明显较高，差异对比P<0.05。结论在COPD患者急性发作期中对纤维蛋白原及C反应蛋白进行检测，可对治疗效果及病情进行有效判断，值得推广应用。